Augurex is a clinical diagnostics leader advancing biomarker-driven solutions for the early detection and management of autoimmune diseases. Our lead products include JOINTstat® (14-3-3eta), which supports the diagnosis and monitoring of rheumatoid arthritis (RA), and SPINEstat™ (Anti-14-3-3eta Multiplex), a first-in-class blood test that aids in the diagnosis of axial spondyloarthritis (axSpA) and helps distinguish it from mechanical back pain. By enabling earlier, more precise diagnosis and better disease management, we empower clinicians and patients with the tools to take control of disease and improve long-term outcomes.
Company Details
- Employees
- 21
- Founded
- 2007
- Address
- 887 Great Northern Way, Suite 125-1,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- augurex.com
- HQ
- Vancouver, British Columbia
Augurex Life Sciences Corp. Questions
Augurex Life Sciences Corp.'s website is augurex.com
Augurex Life Sciences Corp.'s LinkedIn profile is https://ca.linkedin.com/company/augurex-life-sciences-corp-
Augurex Life Sciences Corp. has
21 employees.
View email and phone details for 21
employees at Augurex Life Sciences Corp..
Augurex Life Sciences Corp.'s industry is
Biotechnology Research
Augurex Life Sciences Corp.'s top competitors are
Aspect Biosystems,
Xenon Pharmaceuticals Inc.,
Zymeworks Inc.,
Acuitas Therapeutics,
Abcellera,
Eupraxia Pharmaceuticals Inc.,
Life Sciences Bc,
Kapoose Creek Bio,
Stemcell Technologies,
Seragene Therapeutics.
Augurex Life Sciences Corp.'s categories are Biotechnology Research
Augurex Life Sciences Corp.'s founding year is 2007
